Merck & Co., Inc. (MRK)
115.43
-0.18
(-0.16%)
USD |
NYSE |
Mar 16, 16:00
115.29
-0.14
(-0.12%)
Pre-Market: 07:45
Merck Total Liabilities (Quarterly) : 84.20B for Dec. 31, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Amgen, Inc. | 81.93B |
| Biogen, Inc. | 11.18B |
| Gilead Sciences, Inc. | 36.40B |
| Regeneron Pharmaceuticals, Inc. | 9.302B |
| Moderna, Inc. | 3.688B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 136.87B |
| Shareholders Equity (Quarterly) | 52.61B |
| Debt to Equity Ratio | 0.9606 |
| Current Ratio | 1.536 |
| Net Debt Paydown Yield | -0.95% |